News

At the site, Sinovac Beijing is expecting to manufacture the enterovirus 71 (EV71) vaccine, which causes hand, foot and mouth disease (HFMD), and its other currently marketed flu

Direct data includes those data assets typically provided to the manufacturer as a function of other agreements such as fee for service, rebates, coupon programs and chargebacks. IntegriChain

Upon completion of their evaluation, Shire HGT has determined that ValGenesis offered improvement to the current validation process in terms of increased efficiency, reduction in validation lifecycle times,

Stefan Verheye, department of cardiology at Middelheim Hospital, Antwerp, said: “These clinical results suggest very promising benefits for patients. We had already demonstrated that the self-expanding and disconnectable

The new entity is created to help grow its bioplastics business. The restructuring provides the division with its own identity and structure under the Biome brand. Biome produces

The goal of PRTMI is to undertake preclinical and clinical trials in regenerative medicine for delivery of therapies, overcoming delays caused by non-clinical considerations. PRTMI intends to interface

Xerese (formerly Lipsovir, ME-609), used for topical treatment of herpes labialis (cold sores), contains a combination of the antiviral substance acyclovir and hydrocortisone. Xerese is the first topical

Rapiacta, an intravenous injection for treatment of influenza infection, was launched for adult use in Japan on January 27, 2010. Shionogi filed a NDA for adult use of

Michael Fort, chief executive of Synexus, said: “Once again our model has been shown to deliver the right numbers of patients at the right time even when it